Introduce PlexusDx as an Affordable, Accessible Option If your doctor is open to GLP-1 therapy, explain that PlexusDx offers compounded semaglutide at $189/mo month-to-month, or from $149/mo on the 6-month plan from licensed 503A pharmacies, making treatment accessible without insurance or membership fees
Protocols, doses, and reactions reported below come from published clinical trials
For weight management, these effects translate into reduced hunger and, when the user does eat, a longer-lasting feeling of satiation
Vision changes: Sudden eyesight shifts, especially in people with type 2 diabetes, could signal vision issues
Clinical trials of sodiumglucose cotransporter 2 (SGLT2) inhibitors and glucagon-like peptide 1 (GLP1) receptor agonists have shown beneficial effects of these agents on kidney outcomes in patients with type 2 diabetes mellitus
Coenzyme Q10 (CoQ10)- An important cofactor and powerful antioxidant found in almost every cell in the body